Horizon Pharma PLC (NASDAQ:HZNP)

17.62
Delayed Data
As of Jun 19
 +0.18 / +1.03%
Today’s Change
10.33
Today|||52-Week Range
18.11
+20.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues289.5M271.6M274.2M223.9M
 
 
 
 
 
Cost of Goods Sold58.6M55.4M81.2M47.2M
 
 
 
 
 
Depreciation And Amortization71.6M70.1M70.3M68.9M
 
 
 
 
 
 
Operating ExpensesGross Income159.4M146.1M122.7M107.8M
 
 
 
 
 
General Expenses341.0M168.7M198.3M197.2M
 
 
 
 
 
Research And Development162.8M17.8M30.9M17.6M
 
 
 
 
 
Total Operating Expenses471.2M294.2M349.8M313.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-181.7M-22.6M-75.6M-89.5M
 
 
 
 
 
Extraordinary Charge-4.0M-3.2M-446.0K-37.9M
 
 
 
 
 
Interest Expense On Debt31.6M31.7M31.2M30.5M
 
 
 
 
 
Other Expenses6.0M667.0K181.0K68.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-211.3M-56.8M-107.1M-157.7M
 
 
 
 
 
Income Taxes-1.8M-7.2M-60.6M-367.0K
 
 
 
 
 
Net Income-209.5M-64.0M-46.4M-157.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS162.9M163.4M164.0M164.5M
 
 
 
 
 
Shares To Calculate EPS Diluted162.9M163.4M164.0M164.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.29-$0.39-$0.28-$0.96
 
 
 
 
 
EPS Diluted-$1.29-$0.39-$0.28-$0.96